GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Boundless Bio Inc (NAS:BOLD) » Definitions » Change In Other Working Capital

BOLD (Boundless Bio) Change In Other Working Capital : $-0.54 Mil (TTM As of Mar. 2025)


View and export this data going back to 2024. Start your Free Trial

What is Boundless Bio Change In Other Working Capital?

Boundless Bio's Change In Other Working Capital for the quarter that ended in Mar. 2025 was $0.94 Mil. It means Boundless Bio's Other Working Capital increased by $0.94 Mil from Dec. 2024 to Mar. 2025 .

Boundless Bio's Change In Other Working Capital for the fiscal year that ended in Dec. 2024 was $-2.15 Mil. It means Boundless Bio's Other Working Capital declined by $2.15 Mil from Dec. 2023 to Dec. 2024 .

Boundless Bio Change In Other Working Capital Historical Data

The historical data trend for Boundless Bio's Change In Other Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Boundless Bio Change In Other Working Capital Chart

Boundless Bio Annual Data
Trend Dec21 Dec22 Dec23 Dec24
Change In Other Working Capital
-0.46 -1.26 -2.55 -2.15

Boundless Bio Quarterly Data
Dec21 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Change In Other Working Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.67 -0.69 -0.72 -0.08 0.94

Boundless Bio Change In Other Working Capital Calculation

Change In Other Working Capital is any increase or decrease between periods of other working capital that are not otherwise classified.

Change In Other Working Capital for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.54 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Boundless Bio Change In Other Working Capital Related Terms

Thank you for viewing the detailed overview of Boundless Bio's Change In Other Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Boundless Bio Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Boundless Bio Inc (NAS:BOLD) » Definitions » Change In Other Working Capital
Comparable Companies
PPCB PLUR LVTX ANTX ALGS LTRN MLEC FGEN NRSN COEP VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
N/A
Address
10955 Alexandria Way, Suite 100, San Diego, CA, USA, 92121
Website
https://www.boundlessbio.com
Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.